Consistent with the therapeutic efficacy results, tartrate-resistant acid phosphatase (TRAP) staining of osteoclasts further demonstrated that siIRF5@EINI treatment significantly decreased the number of osteoclasts in RA joints and achieved the least severe bone erosion (Supplementary Fig. 27b). The gene discussed is ACP5; the disease is rheumatoid arthritis.